Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 30
Encontrada(s) 1 página(s)

Docta Complutense
Publicación Artículo científico (JournalArticle)

Lymphoma lurks within aged B cells

  • Jiménez-Martínez, V.
  • Martín-Subero, José I.
  • Fernández Pérez, Raúl
Cancer and aging are inextricably linked conditions. However, whether cancer emerges as a byproduct of the aging process or whether aged cells themselves are prone to become neoplastic remains enigmatic. A study by Castro, Shindyapina and colleagues now provides support for the latter by demonstrating that in aged mice that spontaneously develop lymphomas, tumors originate from clonally expanded age-associated B cells.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Benchmarking single-cell RNA sequencing protocols for cell atlas projects

  • Mereu, Elisabetta
  • Lafzi, Atefeh
  • Moutinho, Catia
  • Gut, Marta
  • Gut, Ivo Glynne
  • Heyn, Holger
Single-cell RNA sequencing (scRNA-seq) is the leading technique for characterizing the transcriptomes of individual cells in a sample. The latest protocols are scalable to thousands of cells and are being used to compile cell atlases of tissues, organs and organisms. However, the protocols differ substantially with respect to their RNA capture efficiency, bias, scale and costs, and their relative advantages for different applications are unclear. In the present study, we generated benchmark datasets to systematically evaluate protocols in terms of their power to comprehensively describe cell types and states. We performed a multicenter study comparing 13 commonly used scRNA-seq and single-nucleus RNA-seq protocols applied to a heterogeneous reference sample resource. Comparative analysis revealed marked differences in protocol performance. The protocols differed in library complexity and their ability to detect cell-type markers, impacting their predictive value and suitability for integration into reference cell atlases. These results provide guidance both for individual researchers and for consortium projects such as the Human Cell Atlas., This project has been made possible in part by grant no. 2018-182827 from the Chan Zuckerberg Initiative DAF, an advised fund of the Silicon Valley Community Foundation. H.H. is a Miguel Servet (CP14/00229) researcher funded by the Spanish Institute of Health Carlos III (ISCIII). C.M. is supported by an AECC postdoctoral fellowship. This work has received funding from the European Union’s Horizon 2020 research and innovation program under Marie Skłodowska-Curie grant agreement no. H2020-MSCA-ITN-2015-675752 (Singek), and the Ministerio de Ciencia, Innovación y Universidades (SAF2017-89109-P; AEI/FEDER, UE). S. was supported by the German Research Foundation’s (DFG’s) (GR4980) Behrens-Weise-Foundation. C.Z. was supported by the European Molecular Biology Organization through the long-term fellowship ALTF 673-2017. The snRNA-seq data were generated with support from the National Institute of Allergy and Infectious Diseases (grant no. U24AI118672), I.N. was supported by JST CREST (grant no. JPMJCR16G3) , Japan. A.J., L.E.W., J.W.B. and W.E. were supported by funding from the DFG (EN 1093/2-1 and SFB1243 TP A14). This publication is part of a project (BCLLATLAS) that received funding from the European Research Council under the European Union’s Horizon 2020 research and innovation program (grant agreement no. 810287). Core funding was from the ISCIII and the Generalitat de Catalunya
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Detection of early seeding of Richter transformation in chronic lymphocytic leukemia

  • Nadeu, Ferran
  • Massoni-Badosa, Ramon
  • Ruiz Gil, Sara
  • Marchese, Domenica, 1986-
  • López Bigas, Núria
  • Gut, Ivo Glynne
  • Heyn, Holger
  • Campo, Elias
Richter transformation (RT) is a paradigmatic evolution of chronic lymphocytic leukemia (CLL) into a very aggressive large B cell lymphoma conferring a dismal prognosis. The mechanisms driving RT remain largely unknown. We characterized the whole genome, epigenome and transcriptome, combined with single-cell DNA/RNA-sequencing analyses and functional experiments, of 19 cases of CLL developing RT. Studying 54 longitudinal samples covering up to 19 years of disease course, we uncovered minute subclones carrying genomic, immunogenetic and transcriptomic features of RT cells already at CLL diagnosis, which were dormant for up to 19 years before transformation. We also identified new driver alterations, discovered a new mutational signature (SBS-RT), recognized an oxidative phosphorylation (OXPHOS)high-B cell receptor (BCR)low-signaling transcriptional axis in RT and showed that OXPHOS inhibition reduces the proliferation of RT cells. These findings demonstrate the early seeding of subclones driving advanced stages of cancer evolution and uncover potential therapeutic targets for RT., This study was supported by the la Caixa Foundation (CLLEvolution-LCF/PR/HR17/52150017, Health Research 2017 Program HR17-00221, to E.C.), the European Research Council under the European Union’s Horizon 2020 Research and Innovation Program (810287, BCLLatlas, to E.C., J.I.M.-S., H.H. and I.G.), the Instituto de Salud Carlos III and the European Regional Development Fund Una Manera de Hacer Europa (PMP15/00007 to E.C. and RTI2018-094584-B-I00 to D.C.), the American Association for Cancer Research (2021 AACR-Amgen Fellowship in Clinical/Translational Cancer Research, 21-40-11-NADE to F.N.), the European Hematology Association (EHA Junior Research Grant 2021, RG-202012-00245 to F.N.), the Lady Tata Memorial Trust (International Award for Research in Leukaemia 2021-2022, LADY_TATA_21_3223 to F.N.), the Generalitat de Catalunya Suport Grups de Recerca AGAUR (2017-SGR-1142 to E.C., 2017-SGR-736 to J.I.M.-S. and 2017-SGR-1009 to D.C.), the Accelerator award CRUK/AIRC/AECC joint funder partnership (AECC_AA17_SUBERO to J.I.M.-S.), the Fundació La Marató de TV3 (201924-30 to J.I.M.-S.), the Centro de Investigación Biomédica en Red Cáncer (CIBERONC; CB16/12/00225, CB16/12/00334, CB16/12/00236), the Ministerio de Ciencia e Innovación (PID2020-117185RB-I00 to X.S.P.), the Fundación Asociación Española Contra el Cáncer (FUNCAR-PRYGN211258SUÁR to X.S.P.), the Associazione Italiana per la Ricerca sul Cancro Foundation (AIRC 5 × 1,000 no. 21198 to G.G.) and the CERCA Programme/Generalitat de Catalunya. H.P.-A. is a recipient of a predoctoral fellowship from the Spanish Ministry of Science, Innovation and Universities (FPU19/03110). A.D.-N. is supported by the Department of Education of the Basque Government (PRE_2017_1_0100). E.C. is an Academia Researcher of the Institució Catalana de Recerca i Estudis Avançats of the Generalitat de Catalunya. This work was partially developed at the Center Esther Koplowitz (Barcelona, Spain).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Sampling time-dependent artifacts in single-cell genomics studies

  • Massoni-Badosa, Ramon
  • Iacono, Giovanni
  • Moutinho, Catia
  • Kulis, Marta
  • Palau, Núria
  • Marchese, Domenica, 1986-
  • Rodríguez Ubreva, Javier
  • Ballestar, Esteban
  • Rodríguez Esteban, Gustavo
  • Marsal, Sara
  • Aymerich, Marta
  • Colomer Pujol, Dolors
  • Campo, Elias
  • Julià Cano, Antoni
  • Martín-Subero, José Ignacio
  • Heyn, Holger
Robust protocols and automation now enable large-scale single-cell RNA and ATAC sequencing experiments and their application on biobank and clinical cohorts. However, technical biases introduced during sample acquisition can hinder solid, reproducible results, and a systematic benchmarking is required before entering large-scale data production. Here, we report the existence and extent of gene expression and chromatin accessibility artifacts introduced during sampling and identify experimental and computational solutions for their prevention., HH is a Miguel Servet (CP14/00229) researcher funded by the Spanish Institute of Health Carlos III (ISCIII). CM and MK are supported by AECC postdoctoral fellowships. This work has received funding from the Ministerio de Ciencia, Innovación y Universidades (SAF2017-89109-P; AEI/FEDER, UE). This study was further funded by the Spanish Ministry of Economy and Competitiveness (grant number: IPT-010000-2010- 36, cofunded by the European Regional Development Fund). Core funding is from the ISCIII and the Generalitat de Catalunya. We acknowledge support of the Spanish Ministry of Economy, Industry and Competitiveness (MEIC) to the EMBL partnership, the Centro de Excelencia Severo Ochoa, the CERCA Programme/Generalitat de Catalunya, the Spanish Ministry of Economy, Industry and Competitiveness (MEIC) through the Instituto de Salud Carlos III and the Generalitat de Catalunya through Departament de Salut and Departament d’Empresa i Coneixement. We also acknowledge the Co-financing by the Spanish Ministry of Economy, Industry and Competitiveness (MEIC) with funds from the European Regional Development Fund (ERDF) corresponding to the 2014–2020 Smart Growth Operating Program. We acknowledge the Generalitat de Catalunya Suport Grups de Recerca AGAUR 2017-SGR-736 (to JIMS) and 2017-SGR-1142 (to EC), and CIBERONC (CB16/12/00225 and CB16/12/00334). EC is an ICREA Academia Researcher. This project received support from the European Commission under the projects DocTIS (H2020, SEP-210574908). This publication is part of a project (BCLLATLAS) that has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant agreement No 810287)
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

SPOTlight: seeded NMF regression to deconvolute spatial transcriptomics spots with single-cell transcriptomes

  • Elosua-Bayés, Marc
  • Nieto, Paula
  • Mereu, Elisabetta
  • Gut, Ivo Glynne
  • Heyn, Holger
Spatially resolved gene expression profiles are key to understand tissue organization and function. However, spatial transcriptomics (ST) profiling techniques lack single-cell resolution and require a combination with single-cell RNA sequencing (scRNA-seq) information to deconvolute the spatially indexed datasets. Leveraging the strengths of both data types, we developed SPOTlight, a computational tool that enables the integration of ST with scRNA-seq data to infer the location of cell types and states within a complex tissue. SPOTlight is centered around a seeded non-negative matrix factorization (NMF) regression, initialized using cell-type marker genes and non-negative least squares (NNLS) to subsequently deconvolute ST capture locations (spots). Simulating varying reference quantities and qualities, we confirmed high prediction accuracy also with shallowly sequenced or small-sized scRNA-seq reference datasets. SPOTlight deconvolution of the mouse brain correctly mapped subtle neuronal cell states of the cortical layers and the defined architecture of the hippocampus. In human pancreatic cancer, we successfully segmented patient sections and further fine-mapped normal and neoplastic cell states. Trained on an external single-cell pancreatic tumor references, we further charted the localization of clinical-relevant and tumor-specific immune cell states, an illustrative example of its flexible application spectrum and future potential in digital pathology., Funding: Ministerio de Ciencia, Innovación y Universidades [SAF2017-89109-P, AEI/FEDER to U.E.]; project (BCLLATLAS) that has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme [810287]; Chan Zuckerberg Initiative (in part); Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa and the CERCA Programme/Generalitat de Catalunya; Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III, the Generalitat de Catalunya through Departament de Salut and Departament d’Empresa i Coneixement; Spanish Ministry of Science and Innovation with funds from the European Regional Development Fund (ERDF) corresponding to the 2014–2020 Smart Growth Operating Program. Funding for open access charge: Ministerio de Ciencia, Innovación y Universidades [SAF2017-89109-P, AEI/FEDER to U.E.]
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Systematic benchmarking of single-cell ATAC-sequencing protocols

  • Rop, Florian V. de
  • Rafels-Ybern, Àlbert
  • Marchese, Domenica, 1986-
  • Caratù, Ginevra
  • Iglesias, Marta
  • Najle, Sebastián R.
  • Sebé-Pedrós, Arnau
  • Heyn, Holger
Single-cell assay for transposase-accessible chromatin by sequencing (scATAC-seq) has emerged as a powerful tool for dissecting regulatory landscapes and cellular heterogeneity. However, an exploration of systemic biases among scATAC-seq technologies has remained absent. In this study, we benchmark the performance of eight scATAC-seq methods across 47 experiments using human peripheral blood mononuclear cells (PBMCs) as a reference sample and develop PUMATAC, a universal preprocessing pipeline, to handle the various sequencing data formats. Our analyses reveal significant differences in sequencing library complexity and tagmentation specificity, which impact cell-type annotation, genotype demultiplexing, peak calling, differential region accessibility and transcription factor motif enrichment. Our findings underscore the importance of sample extraction, method selection, data processing and total cost of experiments, offering valuable guidance for future research. Finally, our data and analysis pipeline encompasses 169,000 PBMC scATAC-seq profiles and a best practices code repository for scATAC-seq data analysis, which are freely available to extend this benchmarking effort to future protocols., H.H. received support for the project PID2020-115439GB-I00 funded by MCIN/AEI/10.13039/501100011033. This publication is also supported as part of a project (BCLLATLAS and ESPACE) that has received funding from the European Research Council under the European Union’s Horizon 2020 Research and Innovation Programme (grant agreement numbers 810287 and 874710). This work was supported by a European Research Council Consolidator grant to S.A. (724226_cis-CONTROL), KU Leuven (C14/22/125 to S.A.), Foundation Against Cancer (F/2020/1396 to S.A.), F.W.O. (grants G0I2722N, G0B5619N and G094121N to S.A. and a PhD fellowship to F.D.) and Aligning Science Across Parkinson’s (grant number ASAP-000430 to S.A.). K.B.M. and S.A.T. are supported by Wellcome (WT211276/Z/18/Z and Sanger core grant WT206194). Computing was performed at the Vlaams Supercomputer Center and high-throughput sequencing at the Genomics Core Leuven. M.R.C. is supported by the National Institutes on Aging K99/R00AG059918. This work was supported by funding from the Rita Allen Foundation (W.J.G.) and the Human Frontiers Science Program (RGY006S; W.J.G.). W.J.G. is a Chan Zuckerberg Biohub investigator and acknowledges grants 2017-174468 and 2018-182817 from the Chan Zuckerberg Initiative and National Institutes of Health grants RM1-HG007735, UM1-HG009442, UM1-HG009436, R01-HG00990901 and U19-AI057266 (to W.J.G.). W.J.G. acknowledges funding from Emerson Collective. B.D. received financial support by Swiss National Science Foundation 310030_197082 and the EPFL. L.S.L. receives support from an Emmy Noether fellowship by the German Research Foundation (LU 2336/2-1), a National Institutes of Health grant UM1HG012076, a Longevity Impetus grant and a Hector Research Career Development Award by the Hector Fellow Academy. A.C.A. is supported by National Institutes of Health grants RF1-MH128842, R35-GM124704 and R01-DA047237 as well as a Silver Family Foundation Innovator Award.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Systematic mapping of organism-scale gene-regulatory networks in aging using population asynchrony

  • Eder, Matthias
  • Martin, Olivier M. F.
  • Oswal, Natasha
  • Sedlackova, Lucia
  • Moutinho, Catia
  • Carmen Fabregat, Andrea del
  • Menéndez Bravo, Simón
  • Sebé-Pedrós, Arnau
  • Heyn, Holger
  • Stroustrup, Nicholas
In aging, physiologic networks decline in function at rates that differ between individuals, producing a wide distribution of lifespan. Though 70% of human lifespan variance remains unexplained by heritable factors, little is known about the intrinsic sources of physiologic heterogeneity in aging. To understand how complex physiologic networks generate lifespan variation, new methods are needed. Here, we present Asynch-seq, an approach that uses gene-expression heterogeneity within isogenic populations to study the processes generating lifespan variation. By collecting thousands of single-individual transcriptomes, we capture the Caenorhabditis elegans "pan-transcriptome"-a highly resolved atlas of non-genetic variation. We use our atlas to guide a large-scale perturbation screen that identifies the decoupling of total mRNA content between germline and soma as the largest source of physiologic heterogeneity in aging, driven by pleiotropic genes whose knockdown dramatically reduces lifespan variance. Our work demonstrates how systematic mapping of physiologic heterogeneity can be applied to reduce inter-individual disparities in aging., We thank Javier Apfeld, Ben Lehner, Elvan Böke, Jonathan Frazer, Chris Sander, and James Sharpe for critical reading of our manuscript and all members of the Dynamics of Living Systems group for discussions and encouragement throughout the project. We thank Joy Alcedo (Wayne State University) for nematode strains. Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). We acknowledge support of the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S, MCIN/AEI /10.13039/501100011033), the Generalitat de Catalunya through the CERCA programme, and to the EMBL partnership. We are grateful to the CRG Core Technologies Programme for their support and assistance in this work, including the CRG Advanced Light Microscopy Unit. This work was technically supported by the EMBL Genomics Core facility. We acknowledge support from the MEIC Excelencia awards BFU2017-88615-P, PID2020-115189GB-I00, and PID2020-115439GB-I00, support from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement No 852201), and support as part of a project (BCLLATLAS) that has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 Research and Innovation Programme (grant agreement no. 810287 and 874710), and support from an award from the Glenn Foundation for Medical Research. Research for this publication has been partially carried out in the Barcelona Collaboratorium for Modelling and Predictive Biology. Research in A.S.-P. group was supported by the European Research Council (ERC-StG 851647), the Spanish Ministry of Science and Innovation (PID2021-124757NB-I00), and AGAUR (2021-SGR2021-01219).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

ATM germline variants in a young adult with chronic lymphocytic leukemia: 8 years of genomic evolution

  • Royo, Romina
  • Magnano, Laura
  • Delgado González, Julio
  • Ruiz Gil, Sara
  • Gelpí, Josep Lluís
  • Heyn, Holger
  • Taylor, Malcom A.
  • Stankovic, Tatjana
  • Puente, Xosé S.
  • Nadeu, Ferran
  • Campo, Elias
The authors thank the Hematopathology Collection registered at the Biobank of Hospital Clínic—Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) as well as Sílvia Martín for the technical support. This study was supported by the “la Caixa” Foundation (CLLEvolution-LCF/PR/HR17/52150017, Health Research 2017 Program HR17-00221, to EC), the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (810287, BCLLatlas, to EC, and HH), CERCA Program/Generalitat de Catalunya, Generalitat de Catalunya Suport Grups de Recerca AGAUR 2017-SGR-1142 (to EC), CIBERONC (CB16/12/00225 to EC), Ministerio de Ciencia e Innovación PID2020-117185RB-I00 (to XSP), FEDER: European Regional Development Fund “Una manera de hacer Europa”, and Fundación Asociación Española Contra el Cáncer FUNCAR-PRYGN211258SUÁR (to XSP). The authors thankfully acknowledge the computer resources at MareNostrum4 and the technical support provided by Barcelona Supercomputing Center (RES activity BCV-2018-3-0001). FN acknowledge research support from the American Association for Cancer Research (2021 AACR-Amgen Fellowship in Clinical/Translational Cancer Research, Grant Number 21-40-11-NADE), the European Hematology Association (EHA Junior Research Grant 2021, Grant Number RG-202012-00245), and the Lady Tata Memorial Trust (International Award for Research in Leukemia 2021–2022, Grant Number LADY_TATA_21_3223). EC is an Academia Researcher of the “Institució Catalana de Recerca i Estudis Avançats” (ICREA) of the Generalitat de Catalunya. This work was partially developed at the Centre Esther Koplowitz (CEK, Barcelona, Spain).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

A single-cell tumor immune atlas for precision oncology

  • Nieto, Paula
  • Elosua-Bayés, Marc
  • Trincado Alonso, Juan Luis, 1987-
  • Marchese, Domenica, 1986-
  • Massoni-Badosa, Ramon
  • Nieto, Juan C.
  • Aguilar-Fernández, Sergio
  • Mereu, Elisabetta
  • Moutinho, Catia
  • Ruiz, Sara
  • Lorden, Patricia
  • Gut, Ivo Glynne
  • Heyn, Holger
The tumor immune microenvironment is a main contributor to cancer progression and a promising therapeutic target for oncology. However, immune microenvironments vary profoundly between patients, and biomarkers for prognosis and treatment response lack precision. A comprehensive compendium of tumor immune cells is required to pinpoint predictive cellular states and their spatial localization. We generated a single-cell tumor immune atlas, jointly analyzing published data sets of >500,000 cells from 217 patients and 13 cancer types, providing the basis for a patient stratification based on immune cell compositions. Projecting immune cells from external tumors onto the atlas facilitated an automated cell annotation system. To enable in situ mapping of immune populations for digital pathology, we applied SPOTlight, combining single-cell and spatial transcriptomics data and identifying colocalization patterns of immune, stromal, and cancer cells in tumor sections. We expect the tumor immune cell atlas, together with our versatile toolbox for precision oncology, to advance currently applied stratification approaches for prognosis and immunotherapy., This publication is part of a project (BCLLATLAS) that has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement No. 810287). This work has received funding from the Ministerio de Ciencia, Innovación y Universidades (SAF2017-89109-P; AEI/FEDER, UE) and the Fundació La Marató de TV3 (201903-30-31-32).We further acknowledge funding from the St. Vincent’s Clinic Foundation (V.T.C.) and the National Health and Medical Research Council Investigator Grant (APP1175781, J.E.P.), the Fundación Asociación Española contra el Cáncer (AECC), FERO (EDM), Ramón Areces Foundation, Cellex Foundation, BBVA (CAIMI), the ISCIII, FIS (PI16/01278), Juan de la Cierva formación fellowship (C.R.-P.) and Sara Borrell fellowship (E.P.-R.). Core funding is from the ISCIII and the Generalitat de Catalunya. We acknowledge support of the Spanish Ministry of Economy, Industry and Competitiveness (MEIC) to the EMBL partnership, the Centro de Excelencia Severo Ochoa, the CERCA Programme / Generalitat de Catalunya, the Spanish Ministry of Economy, Industry and Competitiveness (MEIC) through the nstituto de Salud Carlos III and the Generalitat de Catalunya through Departament de Salut and Departament d’Empresa i Coneixement. We also acknowledge the cofinancing by the Spanish Ministry of Economy, Industry and Competitiveness (MEIC) with funds from the European Regional Development Fund (ERDF) corresponding to the 2014–2020 Smart Growth Operating Program
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

A method for multiplexed full-length single-molecule sequencing of the human mitochondrial genome

  • Keraite, Ieva
  • Becker, Philipp
  • Canevazzi, Davide
  • Frias-López, Cristina
  • Dabad, Marc
  • Tonda, Raúl
  • Paramonov, Ida
  • Ingham, Matthew
  • Brun-Heath, Isabelle
  • Leno, Jordi
  • Abulí, Anna
  • García-Arumí, Elena
  • Heath, Simon
  • Gut, Marta
  • Gut, Ivo Glynne
Methods to reconstruct the mitochondrial DNA (mtDNA) sequence using short-read sequencing come with an inherent bias due to amplification and mapping. They can fail to determine the phase of variants, to capture multiple deletions and to cover the mitochondrial genome evenly. Here we describe a method to target, multiplex and sequence at high coverage full-length human mitochondrial genomes as native single-molecules, utilizing the RNA-guided DNA endonuclease Cas9. Combining Cas9 induced breaks, that define the mtDNA beginning and end of the sequencing reads, as barcodes, we achieve high demultiplexing specificity and delineation of the full-length of the mtDNA, regardless of the structural variant pattern. The long-read sequencing data is analysed with a pipeline where our custom-developed software, baldur, efficiently detects single nucleotide heteroplasmy to below 1%, physically determines phase and can accurately disentangle complex deletions. Our workflow is a tool for studying mtDNA variation and will accelerate mitochondrial research., This research has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 824110 – EASI-Genomics (I.G.G.) and the ERC Synergy project BCLL@las under grant agreement No 810287 (I.G.G.). Institutional support was from the Spanish Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias and cofunded with ERDF funds (PI19/01772). We acknowledge the institutional support of the Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III and the 2014–2020 Smart Growth Operating Program, to the EMBL partnership and institutional co-financing with the European Regional Development Fund (MINECO/FEDER, BIO2015-71792-P). We also acknowledge the support of the Centro de Excelencia Severo Ochoa, and the Generalitat de Catalunya through the Departament de Salut, Departament d’Empresa i Coneixement and the CERCA Programme to the institute.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

A single-cell tumor immune atlas for precision oncology

  • Nieto, Paula
  • Elosua Bayés, Marc
  • Trincado, Juan L.
  • Marchese, Domenica
  • Massoni Badosa, Ramon
  • Salvany, Maria
  • Henriques, Ana
  • Nieto, Juan
  • Aguilar Fernández, Sergio
  • Mereu, Elisabetta
  • Moutinho, Cátia
  • Ruiz, Sara
  • Lorden, Patricia
  • Chin, Vanessa T.
  • Kaczorowski, Dominik
  • Chan, Chia-Ling
  • Gallagher, Richard
  • Chou, Angela
  • Planas Rigol, Ester
  • Rubio Perez, Carlota
  • Gut, Ivo G.
  • Piulats, Josep M.
  • Seoane, Joan
  • Powell, Joseph E.
  • Batlle, Eduard
  • Heyn, Holger
The tumor immune microenvironment is a main contributor to cancer progression and a promising therapeutic target for oncology. However, immune microenvironments vary profoundly between patients, and biomarkers for prognosis and treatment response lack precision. A comprehensive compendium of tumor immune cells is required to pinpoint predictive cellular states and their spatial localization. We generated a single-cell tumor immune atlas, jointly analyzing published data sets of >500,000 cells from 217 patients and 13 cancer types, providing the basis for a patient stratification based on immune cell compositions. Projecting immune cells from external tumors onto the atlas facilitated an automated cell annotation system. To enable in situ mapping of immune populations for digital pathology, we applied SPOTlight, combining single-cell and spatial transcriptomics data and identifying colocalization patterns of immune, stromal, and cancer cells in tumor sections. We expect the tumor immune cell atlas, together with our versatile toolbox for precision oncology, to advance currently applied stratification approaches for prognosis and immunotherapy.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia

  • Syrykh, Charlotte
  • Pons-Brun, Berta
  • Russiñol, Núria
  • Playa-Albinyana, Heribert
  • Baumann, Tycho
  • Duran-Ferrer, Martí
  • Kulis, Marta
  • Carbó-Meix, Anna
  • Mozas, Pablo
  • Alcoceba, Miguel
  • González, Marcos
  • Navarro-Bailón, Almudena
  • Colado, Enrique
  • Payer, Ángel R.
  • Aymerich, Marta
  • Terol, María José
  • Lu, Junyan
  • Knisbacher, Binyamin A.
  • Hahn, Cynthia K.
  • Ruiz-Gaspà, Sílvia
  • Enjuanes, Anna
  • Wu, Catherine J.
  • Getz, Gad
  • Zenz, Thorsten
  • López-Guillermo, Armando
  • Martín-Subero, José Ignacio
  • Colomer, Dolors
  • Delgado, Julio
  • Campo, Elías
  • Nadeu, Ferran
Chronic lymphocytic leukemia (CLL) has high biological and clinical heterogeneity.1,2 A few prognostic factors are used in clinical practice, including immunoglobulin heavy-chain variable (IGHV) gene somatic hypermutation (SHM) status, chromosome aberrations, and gene mutations, which remain insufficient for personalized patient management.3,4 Recent studies have shown that expression of the immunoglobulin lambda light chain IGLV3-21 gene carrying an SHM-derived G>C mutation changing the glycine at position 110 to an arginine (IGLV3-21R110) defines a subset of CLL with an intermediate epigenetic profile and an aggressive clinical course.5,6 When occurring on the IGLV3-21∗01 or ∗04 alleles, the R110 mutation allows homotypic B-cell receptor (BCR) interactions, triggering cell-autonomous BCR signaling5,7 and/or facilitating T-cell–independent engagement with superantigen.8 IGLV3-21R110 has been detected in up to 6.5% of patients with CLL at diagnosis and in up to 25% of patients enrolled in clinical trials.5,6,9 We6 and others5 have shown that all CLL cases belonging to aggressive stereotyped subset #2 carried the IGLV3-21R110. Nonetheless, approximately half of IGLV3-21R110 CLL are not classified as stereotyped subset #2 but seem to have a similar clinical outcome,5,6 suggesting that the conventional stereotyped subset #2 classification might not completely recognize this clinically aggressive subgroup of CLL. In addition, IGLV3-21R110 seems to have a prognostic value independent of the IGHV gene SHM status and methylation–based epigenetic subtypes.5,6 However, further studies in independent cohorts are needed to support its application in clinical practice.1,2,10-12 The aim of this study was to assess the prognostic value of IGLV3-21R110 in large and independent population-based cohorts of patients with CLL., This study was supported by the “la Caixa” Foundation (CLLEvolution - LCF/PR/HR17/52150017 [HR17-00221LCF] and CLLSYSTEMS - LCF/PR/HR22/52420015 [HR22-00172] Health Research 2017 and 2022 Programs; E. Colado), the Ministry of Science and Innovation (MCIN/AEI/10.13039/501100011033) and the European Regional Development Fund “Una manera de hacer Europa” (PID2021-123054OB-I00; E. Campo), European Union (EU) NextGenerationEU/Mecanismo para la Recuperación y la Resiliencia and the Instituto de Salud Carlos III (PMP15/00007; E. Campo), the European Research Council under the EU’s Horizon 2020 Research and Innovation Program (810287, BCLLatlas; E. Campo and J.I.M.-S.), the Generalitat de Catalunya Suport Grups de Recerca AGAUR (2017-SGR-1142 and 2021-SGR-01172; E. Campo), the National Institutes of Health/National Cancer Institute grant P01 CA206978 (C.J.W. and G.G.), and the Centro de Investigación Biomédica en Red de Cáncer. H.P.-A. is a recipient of a predoctoral fellowship from the Spanish Ministry of Universities (FPU19/03110). M.D.-F. acknowledges research support from the Asociación Española Contra el Cáncer Scientific Foundation. B.A.K. was supported by a long-term European Molecular Biology Organization fellowship (ALTF 14-2018). C.K.H. was supported by the National Heart, Lung, and Blood Institute Training Program in Molecular Hematology (T32HL116324). F.N. acknowledges research support from the American Association for Cancer Research (2021 AACR-Amgen Fellowship in Clinical/Translational Cancer Research, 21-40-11-NADE), European Hematology Association (EHA Junior Research grant 2021, RG-202012-00245), and Lady Tata Memorial Trust (International Award for Research in Leukaemia 2021-2022, LADY_TATA_21_3223). E. Campo is an academia researcher of the “Institució Catalana de Recerca I Estudis Avançats” of the Generalitat de Catalunya. This work was partially developed at the Centre Esther Koplowitz (Barcelona, Spain)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Sampling time-dependent artifacts in single-cell genomics studies

  • Massoni-Badosa, Ramon
  • Iacono, Giovanni
  • Moutinho, Catia
  • Kulis, Marta
  • Palau, Núria
  • Marchese, Domenica, 1986-
  • Rodríguez Ubreva, Javier
  • Ballestar, Esteban
  • Rodríguez Esteban, Gustavo
  • Marsal, Sara
  • Aymerich, Marta
  • Colomer Pujol, Dolors
  • Campo, Elias
  • Julià Cano, Antoni
  • Martín-Subero, José Ignacio
  • Heyn, Holger
Robust protocols and automation now enable large-scale single-cell RNA and ATAC sequencing experiments and their application on biobank and clinical cohorts. However, technical biases introduced during sample acquisition can hinder solid, reproducible results, and a systematic benchmarking is required before entering large-scale data production. Here, we report the existence and extent of gene expression and chromatin accessibility artifacts introduced during sampling and identify experimental and computational solutions for their prevention., HH is a Miguel Servet (CP14/00229) researcher funded by the Spanish Institute of Health Carlos III (ISCIII). CM and MK are supported by AECC postdoctoral fellowships. This work has received funding from the Ministerio de Ciencia, Innovación y Universidades (SAF2017-89109-P; AEI/FEDER, UE). This study was further funded by the Spanish Ministry of Economy and Competitiveness (grant number: IPT-010000-2010- 36, cofunded by the European Regional Development Fund). Core funding is from the ISCIII and the Generalitat de Catalunya. We acknowledge support of the Spanish Ministry of Economy, Industry and Competitiveness (MEIC) to the EMBL partnership, the Centro de Excelencia Severo Ochoa, the CERCA Programme/Generalitat de Catalunya, the Spanish Ministry of Economy, Industry and Competitiveness (MEIC) through the Instituto de Salud Carlos III and the Generalitat de Catalunya through Departament de Salut and Departament d’Empresa i Coneixement. We also acknowledge the Co-financing by the Spanish Ministry of Economy, Industry and Competitiveness (MEIC) with funds from the European Regional Development Fund (ERDF) corresponding to the 2014–2020 Smart Growth Operating Program. We acknowledge the Generalitat de Catalunya Suport Grups de Recerca AGAUR 2017-SGR-736 (to JIMS) and 2017-SGR-1142 (to EC), and CIBERONC (CB16/12/00225 and CB16/12/00334). EC is an ICREA Academia Researcher. This project received support from the European Commission under the projects DocTIS (H2020, SEP-210574908). This publication is part of a project (BCLLATLAS) that has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant agreement No 810287)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Detection of early seeding of Richter transformation in chronic lymphocytic leukemia

Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A method for multiplexed full-length single-molecule sequencing of the human mitochondrial genome

  • Keraite, Ieva
  • Becker, Philipp
  • Canevazzi, Davide
  • Frías-López, Cristina
  • Dabad, Marc
  • Leno Colorado, Jorge
  • Abulí Vidal, Anna
  • García Arumí, Elena
  • Tonda, Raul
Data processing; DNA sequencing; Genomic analysis, Tratamiento de datos; Secuenciación de ADN; Análisis genómico, Tractament de dades; Seqüenciació d'ADN; Anàlisi genòmica, Methods to reconstruct the mitochondrial DNA (mtDNA) sequence using short-read sequencing come with an inherent bias due to amplification and mapping. They can fail to determine the phase of variants, to capture multiple deletions and to cover the mitochondrial genome evenly. Here we describe a method to target, multiplex and sequence at high coverage full-length human mitochondrial genomes as native single-molecules, utilizing the RNA-guided DNA endonuclease Cas9. Combining Cas9 induced breaks, that define the mtDNA beginning and end of the sequencing reads, as barcodes, we achieve high demultiplexing specificity and delineation of the full-length of the mtDNA, regardless of the structural variant pattern. The long-read sequencing data is analysed with a pipeline where our custom-developed software, baldur, efficiently detects single nucleotide heteroplasmy to below 1%, physically determines phase and can accurately disentangle complex deletions. Our workflow is a tool for studying mtDNA variation and will accelerate mitochondrial research., This research has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 824110 – EASI-Genomics (I.G.G.) and the ERC Synergy project BCLL@las under grant agreement No 810287 (I.G.G.). Institutional support was from the Spanish Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias and cofunded with ERDF funds (PI19/01772). We acknowledge the institutional support of the Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III and the 2014–2020 Smart Growth Operating Program, to the EMBL partnership and institutional co-financing with the European Regional Development Fund (MINECO/FEDER, BIO2015-71792-P). We also acknowledge the support of the Centro de Excelencia Severo Ochoa, and the Generalitat de Catalunya through the Departament de Salut, Departament d’Empresa i Coneixement and the CERCA Programme to the institute.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A single-cell tumor immune atlas for precision oncology

  • Nieto, Paula
  • Elosua-Bayés, Marc
  • Trincado Alonso, Juan Luis, 1987-
  • Marchese, Domenica, 1986-
  • Massoni-Badosa, Ramon
  • Nieto, Juan C.
  • Aguilar-Fernández, Sergio
  • Mereu, Elisabetta
  • Moutinho, Catia
  • Ruiz, Sara
  • Lorden, Patricia
  • Gut, Ivo Glynne
  • Heyn, Holger
The tumor immune microenvironment is a main contributor to cancer progression and a promising therapeutic target for oncology. However, immune microenvironments vary profoundly between patients, and biomarkers for prognosis and treatment response lack precision. A comprehensive compendium of tumor immune cells is required to pinpoint predictive cellular states and their spatial localization. We generated a single-cell tumor immune atlas, jointly analyzing published data sets of >500,000 cells from 217 patients and 13 cancer types, providing the basis for a patient stratification based on immune cell compositions. Projecting immune cells from external tumors onto the atlas facilitated an automated cell annotation system. To enable in situ mapping of immune populations for digital pathology, we applied SPOTlight, combining single-cell and spatial transcriptomics data and identifying colocalization patterns of immune, stromal, and cancer cells in tumor sections. We expect the tumor immune cell atlas, together with our versatile toolbox for precision oncology, to advance currently applied stratification approaches for prognosis and immunotherapy., This publication is part of a project (BCLLATLAS) that has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement No. 810287). This work has received funding from the Ministerio de Ciencia, Innovación y Universidades (SAF2017-89109-P; AEI/FEDER, UE) and the Fundació La Marató de TV3 (201903-30-31-32).We further acknowledge funding from the St. Vincent’s Clinic Foundation (V.T.C.) and the National Health and Medical Research Council Investigator Grant (APP1175781, J.E.P.), the Fundación Asociación Española contra el Cáncer (AECC), FERO (EDM), Ramón Areces Foundation, Cellex Foundation, BBVA (CAIMI), the ISCIII, FIS (PI16/01278), Juan de la Cierva formación fellowship (C.R.-P.) and Sara Borrell fellowship (E.P.-R.). Core funding is from the ISCIII and the Generalitat de Catalunya. We acknowledge support of the Spanish Ministry of Economy, Industry and Competitiveness (MEIC) to the EMBL partnership, the Centro de Excelencia Severo Ochoa, the CERCA Programme / Generalitat de Catalunya, the Spanish Ministry of Economy, Industry and Competitiveness (MEIC) through the nstituto de Salud Carlos III and the Generalitat de Catalunya through Departament de Salut and Departament d’Empresa i Coneixement. We also acknowledge the cofinancing by the Spanish Ministry of Economy, Industry and Competitiveness (MEIC) with funds from the European Regional Development Fund (ERDF) corresponding to the 2014–2020 Smart Growth Operating Program
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Systematic benchmarking of single-cell ATAC-sequencing protocols

  • Rop, Florian V. de
  • Rafels-Ybern, Àlbert
  • Marchese, Domenica, 1986-
  • Caratù, Ginevra
  • Iglesias, Marta
  • Najle, Sebastián R.
  • Sebé-Pedrós, Arnau
  • Heyn, Holger
Single-cell assay for transposase-accessible chromatin by sequencing (scATAC-seq) has emerged as a powerful tool for dissecting regulatory landscapes and cellular heterogeneity. However, an exploration of systemic biases among scATAC-seq technologies has remained absent. In this study, we benchmark the performance of eight scATAC-seq methods across 47 experiments using human peripheral blood mononuclear cells (PBMCs) as a reference sample and develop PUMATAC, a universal preprocessing pipeline, to handle the various sequencing data formats. Our analyses reveal significant differences in sequencing library complexity and tagmentation specificity, which impact cell-type annotation, genotype demultiplexing, peak calling, differential region accessibility and transcription factor motif enrichment. Our findings underscore the importance of sample extraction, method selection, data processing and total cost of experiments, offering valuable guidance for future research. Finally, our data and analysis pipeline encompasses 169,000 PBMC scATAC-seq profiles and a best practices code repository for scATAC-seq data analysis, which are freely available to extend this benchmarking effort to future protocols., H.H. received support for the project PID2020-115439GB-I00 funded by MCIN/AEI/10.13039/501100011033. This publication is also supported as part of a project (BCLLATLAS and ESPACE) that has received funding from the European Research Council under the European Union’s Horizon 2020 Research and Innovation Programme (grant agreement numbers 810287 and 874710). This work was supported by a European Research Council Consolidator grant to S.A. (724226_cis-CONTROL), KU Leuven (C14/22/125 to S.A.), Foundation Against Cancer (F/2020/1396 to S.A.), F.W.O. (grants G0I2722N, G0B5619N and G094121N to S.A. and a PhD fellowship to F.D.) and Aligning Science Across Parkinson’s (grant number ASAP-000430 to S.A.). K.B.M. and S.A.T. are supported by Wellcome (WT211276/Z/18/Z and Sanger core grant WT206194). Computing was performed at the Vlaams Supercomputer Center and high-throughput sequencing at the Genomics Core Leuven. M.R.C. is supported by the National Institutes on Aging K99/R00AG059918. This work was supported by funding from the Rita Allen Foundation (W.J.G.) and the Human Frontiers Science Program (RGY006S; W.J.G.). W.J.G. is a Chan Zuckerberg Biohub investigator and acknowledges grants 2017-174468 and 2018-182817 from the Chan Zuckerberg Initiative and National Institutes of Health grants RM1-HG007735, UM1-HG009442, UM1-HG009436, R01-HG00990901 and U19-AI057266 (to W.J.G.). W.J.G. acknowledges funding from Emerson Collective. B.D. received financial support by Swiss National Science Foundation 310030_197082 and the EPFL. L.S.L. receives support from an Emmy Noether fellowship by the German Research Foundation (LU 2336/2-1), a National Institutes of Health grant UM1HG012076, a Longevity Impetus grant and a Hector Research Career Development Award by the Hector Fellow Academy. A.C.A. is supported by National Institutes of Health grants RF1-MH128842, R35-GM124704 and R01-DA047237 as well as a Silver Family Foundation Innovator Award.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Systematic mapping of organism-scale gene-regulatory networks in aging using population asynchrony

  • Eder, Matthias
  • Martin, Olivier M. F.
  • Oswal, Natasha
  • Sedlackova, Lucia
  • Moutinho, Catia
  • Carmen Fabregat, Andrea del
  • Menéndez Bravo, Simón
  • Sebé-Pedrós, Arnau
  • Heyn, Holger
  • Stroustrup, Nicholas
In aging, physiologic networks decline in function at rates that differ between individuals, producing a wide distribution of lifespan. Though 70% of human lifespan variance remains unexplained by heritable factors, little is known about the intrinsic sources of physiologic heterogeneity in aging. To understand how complex physiologic networks generate lifespan variation, new methods are needed. Here, we present Asynch-seq, an approach that uses gene-expression heterogeneity within isogenic populations to study the processes generating lifespan variation. By collecting thousands of single-individual transcriptomes, we capture the Caenorhabditis elegans "pan-transcriptome"-a highly resolved atlas of non-genetic variation. We use our atlas to guide a large-scale perturbation screen that identifies the decoupling of total mRNA content between germline and soma as the largest source of physiologic heterogeneity in aging, driven by pleiotropic genes whose knockdown dramatically reduces lifespan variance. Our work demonstrates how systematic mapping of physiologic heterogeneity can be applied to reduce inter-individual disparities in aging., We thank Javier Apfeld, Ben Lehner, Elvan Böke, Jonathan Frazer, Chris Sander, and James Sharpe for critical reading of our manuscript and all members of the Dynamics of Living Systems group for discussions and encouragement throughout the project. We thank Joy Alcedo (Wayne State University) for nematode strains. Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). We acknowledge support of the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S, MCIN/AEI /10.13039/501100011033), the Generalitat de Catalunya through the CERCA programme, and to the EMBL partnership. We are grateful to the CRG Core Technologies Programme for their support and assistance in this work, including the CRG Advanced Light Microscopy Unit. This work was technically supported by the EMBL Genomics Core facility. We acknowledge support from the MEIC Excelencia awards BFU2017-88615-P, PID2020-115189GB-I00, and PID2020-115439GB-I00, support from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement No 852201), and support as part of a project (BCLLATLAS) that has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 Research and Innovation Programme (grant agreement no. 810287 and 874710), and support from an award from the Glenn Foundation for Medical Research. Research for this publication has been partially carried out in the Barcelona Collaboratorium for Modelling and Predictive Biology. Research in A.S.-P. group was supported by the European Research Council (ERC-StG 851647), the Spanish Ministry of Science and Innovation (PID2021-124757NB-I00), and AGAUR (2021-SGR2021-01219).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

ATM germline variants in a young adult with chronic lymphocytic leukemia: 8 years of genomic evolution

  • Royo, Romina
  • Magnano, Laura
  • Delgado González, Julio
  • Ruiz Gil, Sara
  • Gelpí, Josep Lluís
  • Heyn, Holger
  • Taylor, Malcom A.
  • Stankovic, Tatjana
  • Puente, Xosé S.
  • Nadeu, Ferran
  • Campo, Elias
The authors thank the Hematopathology Collection registered at the Biobank of Hospital Clínic—Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) as well as Sílvia Martín for the technical support. This study was supported by the “la Caixa” Foundation (CLLEvolution-LCF/PR/HR17/52150017, Health Research 2017 Program HR17-00221, to EC), the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (810287, BCLLatlas, to EC, and HH), CERCA Program/Generalitat de Catalunya, Generalitat de Catalunya Suport Grups de Recerca AGAUR 2017-SGR-1142 (to EC), CIBERONC (CB16/12/00225 to EC), Ministerio de Ciencia e Innovación PID2020-117185RB-I00 (to XSP), FEDER: European Regional Development Fund “Una manera de hacer Europa”, and Fundación Asociación Española Contra el Cáncer FUNCAR-PRYGN211258SUÁR (to XSP). The authors thankfully acknowledge the computer resources at MareNostrum4 and the technical support provided by Barcelona Supercomputing Center (RES activity BCV-2018-3-0001). FN acknowledge research support from the American Association for Cancer Research (2021 AACR-Amgen Fellowship in Clinical/Translational Cancer Research, Grant Number 21-40-11-NADE), the European Hematology Association (EHA Junior Research Grant 2021, Grant Number RG-202012-00245), and the Lady Tata Memorial Trust (International Award for Research in Leukemia 2021–2022, Grant Number LADY_TATA_21_3223). EC is an Academia Researcher of the “Institució Catalana de Recerca i Estudis Avançats” (ICREA) of the Generalitat de Catalunya. This work was partially developed at the Centre Esther Koplowitz (CEK, Barcelona, Spain).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A single-cell tumor immune atlas for precision oncology

  • Nieto, Paula
  • Elosua Bayés, Marc
  • Trincado, Juan L.
  • Marchese, Domenica
  • Massoni Badosa, Ramon
  • Salvany, Maria
  • Henriques, Ana
  • Nieto, Juan
  • Aguilar Fernández, Sergio
  • Mereu, Elisabetta
  • Moutinho, Cátia
  • Ruiz, Sara
  • Lorden, Patricia
  • Chin, Vanessa T.
  • Kaczorowski, Dominik
  • Chan, Chia-Ling
  • Gallagher, Richard
  • Chou, Angela
  • Planas Rigol, Ester
  • Rubio Perez, Carlota
  • Gut, Ivo G.
  • Piulats, Josep M.
  • Seoane, Joan
  • Powell, Joseph E.
  • Batlle, Eduard
  • Heyn, Holger
The tumor immune microenvironment is a main contributor to cancer progression and a promising therapeutic target for oncology. However, immune microenvironments vary profoundly between patients, and biomarkers for prognosis and treatment response lack precision. A comprehensive compendium of tumor immune cells is required to pinpoint predictive cellular states and their spatial localization. We generated a single-cell tumor immune atlas, jointly analyzing published data sets of >500,000 cells from 217 patients and 13 cancer types, providing the basis for a patient stratification based on immune cell compositions. Projecting immune cells from external tumors onto the atlas facilitated an automated cell annotation system. To enable in situ mapping of immune populations for digital pathology, we applied SPOTlight, combining single-cell and spatial transcriptomics data and identifying colocalization patterns of immune, stromal, and cancer cells in tumor sections. We expect the tumor immune cell atlas, together with our versatile toolbox for precision oncology, to advance currently applied stratification approaches for prognosis and immunotherapy.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Detection of early seeding of Richter transformation in chronic lymphocytic leukemia

  • Nadeu, Ferran
  • Massoni-Badosa, Ramon
  • Ruiz Gil, Sara
  • Marchese, Domenica, 1986-
  • López Bigas, Núria
  • Gut, Ivo Glynne
  • Heyn, Holger
  • Campo, Elias
Richter transformation (RT) is a paradigmatic evolution of chronic lymphocytic leukemia (CLL) into a very aggressive large B cell lymphoma conferring a dismal prognosis. The mechanisms driving RT remain largely unknown. We characterized the whole genome, epigenome and transcriptome, combined with single-cell DNA/RNA-sequencing analyses and functional experiments, of 19 cases of CLL developing RT. Studying 54 longitudinal samples covering up to 19 years of disease course, we uncovered minute subclones carrying genomic, immunogenetic and transcriptomic features of RT cells already at CLL diagnosis, which were dormant for up to 19 years before transformation. We also identified new driver alterations, discovered a new mutational signature (SBS-RT), recognized an oxidative phosphorylation (OXPHOS)high-B cell receptor (BCR)low-signaling transcriptional axis in RT and showed that OXPHOS inhibition reduces the proliferation of RT cells. These findings demonstrate the early seeding of subclones driving advanced stages of cancer evolution and uncover potential therapeutic targets for RT., This study was supported by the la Caixa Foundation (CLLEvolution-LCF/PR/HR17/52150017, Health Research 2017 Program HR17-00221, to E.C.), the European Research Council under the European Union’s Horizon 2020 Research and Innovation Program (810287, BCLLatlas, to E.C., J.I.M.-S., H.H. and I.G.), the Instituto de Salud Carlos III and the European Regional Development Fund Una Manera de Hacer Europa (PMP15/00007 to E.C. and RTI2018-094584-B-I00 to D.C.), the American Association for Cancer Research (2021 AACR-Amgen Fellowship in Clinical/Translational Cancer Research, 21-40-11-NADE to F.N.), the European Hematology Association (EHA Junior Research Grant 2021, RG-202012-00245 to F.N.), the Lady Tata Memorial Trust (International Award for Research in Leukaemia 2021-2022, LADY_TATA_21_3223 to F.N.), the Generalitat de Catalunya Suport Grups de Recerca AGAUR (2017-SGR-1142 to E.C., 2017-SGR-736 to J.I.M.-S. and 2017-SGR-1009 to D.C.), the Accelerator award CRUK/AIRC/AECC joint funder partnership (AECC_AA17_SUBERO to J.I.M.-S.), the Fundació La Marató de TV3 (201924-30 to J.I.M.-S.), the Centro de Investigación Biomédica en Red Cáncer (CIBERONC; CB16/12/00225, CB16/12/00334, CB16/12/00236), the Ministerio de Ciencia e Innovación (PID2020-117185RB-I00 to X.S.P.), the Fundación Asociación Española Contra el Cáncer (FUNCAR-PRYGN211258SUÁR to X.S.P.), the Associazione Italiana per la Ricerca sul Cancro Foundation (AIRC 5 × 1,000 no. 21198 to G.G.) and the CERCA Programme/Generalitat de Catalunya. H.P.-A. is a recipient of a predoctoral fellowship from the Spanish Ministry of Science, Innovation and Universities (FPU19/03110). A.D.-N. is supported by the Department of Education of the Basque Government (PRE_2017_1_0100). E.C. is an Academia Researcher of the Institució Catalana de Recerca i Estudis Avançats of the Generalitat de Catalunya. This work was partially developed at the Center Esther Koplowitz (Barcelona, Spain).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

SPOTlight: seeded NMF regression to deconvolute spatial transcriptomics spots with single-cell transcriptomes

  • Elosua-Bayés, Marc
  • Nieto, Paula
  • Mereu, Elisabetta
  • Gut, Ivo Glynne
  • Heyn, Holger
Spatially resolved gene expression profiles are key to understand tissue organization and function. However, spatial transcriptomics (ST) profiling techniques lack single-cell resolution and require a combination with single-cell RNA sequencing (scRNA-seq) information to deconvolute the spatially indexed datasets. Leveraging the strengths of both data types, we developed SPOTlight, a computational tool that enables the integration of ST with scRNA-seq data to infer the location of cell types and states within a complex tissue. SPOTlight is centered around a seeded non-negative matrix factorization (NMF) regression, initialized using cell-type marker genes and non-negative least squares (NNLS) to subsequently deconvolute ST capture locations (spots). Simulating varying reference quantities and qualities, we confirmed high prediction accuracy also with shallowly sequenced or small-sized scRNA-seq reference datasets. SPOTlight deconvolution of the mouse brain correctly mapped subtle neuronal cell states of the cortical layers and the defined architecture of the hippocampus. In human pancreatic cancer, we successfully segmented patient sections and further fine-mapped normal and neoplastic cell states. Trained on an external single-cell pancreatic tumor references, we further charted the localization of clinical-relevant and tumor-specific immune cell states, an illustrative example of its flexible application spectrum and future potential in digital pathology., Funding: Ministerio de Ciencia, Innovación y Universidades [SAF2017-89109-P, AEI/FEDER to U.E.]; project (BCLLATLAS) that has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme [810287]; Chan Zuckerberg Initiative (in part); Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa and the CERCA Programme/Generalitat de Catalunya; Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III, the Generalitat de Catalunya through Departament de Salut and Departament d’Empresa i Coneixement; Spanish Ministry of Science and Innovation with funds from the European Regional Development Fund (ERDF) corresponding to the 2014–2020 Smart Growth Operating Program. Funding for open access charge: Ministerio de Ciencia, Innovación y Universidades [SAF2017-89109-P, AEI/FEDER to U.E.]
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Benchmarking single-cell RNA sequencing protocols for cell atlas projects

  • Mereu, Elisabetta
  • Lafzi, Atefeh
  • Moutinho, Catia
  • Gut, Marta
  • Gut, Ivo Glynne
  • Heyn, Holger
Single-cell RNA sequencing (scRNA-seq) is the leading technique for characterizing the transcriptomes of individual cells in a sample. The latest protocols are scalable to thousands of cells and are being used to compile cell atlases of tissues, organs and organisms. However, the protocols differ substantially with respect to their RNA capture efficiency, bias, scale and costs, and their relative advantages for different applications are unclear. In the present study, we generated benchmark datasets to systematically evaluate protocols in terms of their power to comprehensively describe cell types and states. We performed a multicenter study comparing 13 commonly used scRNA-seq and single-nucleus RNA-seq protocols applied to a heterogeneous reference sample resource. Comparative analysis revealed marked differences in protocol performance. The protocols differed in library complexity and their ability to detect cell-type markers, impacting their predictive value and suitability for integration into reference cell atlases. These results provide guidance both for individual researchers and for consortium projects such as the Human Cell Atlas., This project has been made possible in part by grant no. 2018-182827 from the Chan Zuckerberg Initiative DAF, an advised fund of the Silicon Valley Community Foundation. H.H. is a Miguel Servet (CP14/00229) researcher funded by the Spanish Institute of Health Carlos III (ISCIII). C.M. is supported by an AECC postdoctoral fellowship. This work has received funding from the European Union’s Horizon 2020 research and innovation program under Marie Skłodowska-Curie grant agreement no. H2020-MSCA-ITN-2015-675752 (Singek), and the Ministerio de Ciencia, Innovación y Universidades (SAF2017-89109-P; AEI/FEDER, UE). S. was supported by the German Research Foundation’s (DFG’s) (GR4980) Behrens-Weise-Foundation. C.Z. was supported by the European Molecular Biology Organization through the long-term fellowship ALTF 673-2017. The snRNA-seq data were generated with support from the National Institute of Allergy and Infectious Diseases (grant no. U24AI118672), I.N. was supported by JST CREST (grant no. JPMJCR16G3) , Japan. A.J., L.E.W., J.W.B. and W.E. were supported by funding from the DFG (EN 1093/2-1 and SFB1243 TP A14). This publication is part of a project (BCLLATLAS) that received funding from the European Research Council under the European Union’s Horizon 2020 research and innovation program (grant agreement no. 810287). Core funding was from the ISCIII and the Generalitat de Catalunya
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A method for multiplexed full-length single-molecule sequencing of the human mitochondrial genome

  • Keraite, Ieva
  • Becker, Philipp
  • Canevazzi, Davide
  • Frias-López, Cristina
  • Dabad, Marc
  • Tonda, Raúl
  • Paramonov, Ida
  • Ingham, Matthew
  • Brun-Heath, Isabelle
  • Leno, Jordi
  • Abulí, Anna
  • García-Arumí, Elena
  • Heath, Simon
  • Gut, Marta
  • Gut, Ivo Glynne
Methods to reconstruct the mitochondrial DNA (mtDNA) sequence using short-read sequencing come with an inherent bias due to amplification and mapping. They can fail to determine the phase of variants, to capture multiple deletions and to cover the mitochondrial genome evenly. Here we describe a method to target, multiplex and sequence at high coverage full-length human mitochondrial genomes as native single-molecules, utilizing the RNA-guided DNA endonuclease Cas9. Combining Cas9 induced breaks, that define the mtDNA beginning and end of the sequencing reads, as barcodes, we achieve high demultiplexing specificity and delineation of the full-length of the mtDNA, regardless of the structural variant pattern. The long-read sequencing data is analysed with a pipeline where our custom-developed software, baldur, efficiently detects single nucleotide heteroplasmy to below 1%, physically determines phase and can accurately disentangle complex deletions. Our workflow is a tool for studying mtDNA variation and will accelerate mitochondrial research., This research has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 824110 – EASI-Genomics (I.G.G.) and the ERC Synergy project BCLL@las under grant agreement No 810287 (I.G.G.). Institutional support was from the Spanish Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias and cofunded with ERDF funds (PI19/01772). We acknowledge the institutional support of the Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III and the 2014–2020 Smart Growth Operating Program, to the EMBL partnership and institutional co-financing with the European Regional Development Fund (MINECO/FEDER, BIO2015-71792-P). We also acknowledge the support of the Centro de Excelencia Severo Ochoa, and the Generalitat de Catalunya through the Departament de Salut, Departament d’Empresa i Coneixement and the CERCA Programme to the institute.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Sampling time-dependent artifacts in single-cell genomics studies

  • Massoni-Badosa, Ramon
  • Iacono, G.
  • Moutinho, Catia|||0000-0003-3885-0847
  • Kulis, M.
  • Palau, Núria
  • Marchese, Domenica|||0000-0002-3036-4580
  • Rodríguez-Ubreva, Javier|||0000-0003-4707-4536
  • Ballestar, Esteban|||0000-0002-1400-2440
  • Rodriguez-Esteban, G.
  • Marsal, Sara|||0000-0001-5515-3854
  • Aymerich, Marta
  • Colomer, Dolors|||0000-0001-7486-8484
  • Campo, Elias|||0000-0001-9850-9793
  • Julià Cano, Antonio|||0000-0001-6064-3620
  • Martin-Subero, Jose Ignacio|||0000-0001-8809-5195
  • Heyn, Holger|||0000-0002-3276-1889
Robust protocols and automation now enable large-scale single-cell RNA and ATAC sequencing experiments and their application on biobank and clinical cohorts. However, technical biases introduced during sample acquisition can hinder solid, reproducible results, and a systematic benchmarking is required before entering large-scale data production. Here, we report the existence and extent of gene expression and chromatin accessibility artifacts introduced during sampling and identify experimental and computational solutions for their prevention.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A single-cell tumor immune atlas for precision oncology

  • Nieto, Paula
  • Elosua-Bayes, Marc|||0000-0001-5315-815X
  • Trincado Alonso, Juan Luis, 1987-|||0000-0001-5363-3774
  • Marchese, Domenica|||0000-0002-3036-4580
  • Massoni-Badosa, Ramon
  • Salvany, Maria|||0000-0002-8573-4032
  • Henriques, Ana|||0000-0002-2421-4308
  • Nieto Sáchica, Juan Camilo|||0000-0002-3400-1488
  • Aguilar-Fernández, Sergio|||0000-0002-8869-1066
  • Mereu, Elisabetta|||0000-0001-6101-8472
  • Moutinho, Catia|||0000-0003-3885-0847
  • Ruiz, Sara
  • Lorden, Patricia
  • Chin, Vanessa T.
  • Kaczorowski, Dominik|||0000-0002-9205-1934
  • Chan, Chia Ling
  • Gallagher, Richard
  • Chou, Angela|||0000-0003-3925-7295
  • Planas-Rigol, Ester|||0000-0001-5948-2241
  • Rubio-Perez, Carlota|||0000-0002-1921-168X
  • Gut, Ivo|||0000-0001-7219-632X
  • Piulats, Josep M.|||0000-0002-3606-1724
  • Seoane Suárez, Joan|||0000-0002-6541-5974
  • Powell, Joseph E.|||0000-0002-5070-4124
  • Batlle, Eduard|||0000-0003-2422-0326
  • Heyn, Holger|||0000-0002-3276-1889
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

BCL3 rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseases

  • Carbo-Meix, Anna
  • Guijarro, Francesca|||0000-0001-6376-0929
  • Wang, Luojun
  • Grau Vorster, Marta|||0000-0003-3779-0387
  • Royo, Romina|||0000-0003-3493-0874
  • Frigola, Gerard|||0000-0001-6794-6456
  • Playa-Albinyana, Heribert
  • Buhler, Marco M.
  • Clot, Guillem|||0000-0003-2588-7413
  • Duran-Ferrer, Marti
  • Lu, Junyan
  • Granada, Isabel|||0000-0002-4275-0104
  • Baptista, Maria Joao|||0000-0003-3471-2535
  • Navarro Ferrando, José Tomás|||0000-0001-9101-6013
  • Espinet Solà, Blanca|||0000-0002-4294-8145
  • Puiggros, Anna|||0000-0001-9627-4978
  • Tapia, Gustavo|||0000-0003-1882-0368
  • Bandiera, Laura
  • De Canal, Gabriella
  • Bonoldi, Emanuela
  • Climent, Fina|||0000-0002-4360-8388
  • Ribera-Cortada, Inmaculada|||0000-0002-3372-828X
  • Fernandez-Caballero, Mariana
  • De la Banda, Esmeralda
  • Do Nascimento, Janilson
  • Pineda, Alberto
  • Vela, Dolors
  • Rozman, Maria|||0000-0002-2641-1110
  • Aymerich, Marta
  • Syrykh, Charlotte
  • Brousset, Pierre
  • Perera, Miguel
  • Yáñez, Lucrecia|||0000-0001-9925-3048
  • Ortin, Jesus Xavier
  • Tuset, Esperanza|||0000-0002-1463-6689
  • Zenz, Thorsten|||0000-0001-7890-9845
  • Cook, James R.
  • Swerdlow, Steven H.
  • Martin-Subero, Jose I.
  • Colomer, Dolors|||0000-0001-7486-8484
  • Matutes, Estella|||0000-0001-6745-7046
  • Bea, Silvia
  • Costa, Dolors|||0000-0002-8276-3292
  • Nadeu, Ferran|||0000-0003-2910-9440
  • Campo, Elias|||0000-0001-9850-9793
The t(14;19)(q32;q13) often juxtaposes BCL3 with immunoglobulin heavy chain (IGH) resulting in overexpression of the gene. In contrast to other oncogenic translocations, BCL3 rearrangement (BCL3-R) has been associated with a broad spectrum of lymphoid neoplasms. Here we report an integrative whole-genome sequence, transcriptomic, and DNA methylation analysis of 13 lymphoid neoplasms with BCL3-R. The resolution of the breakpoints at single base-pair revealed that they occur in two clusters at 5' (n=9) and 3' (n=4) regions of BCL3 associated with two different biological and clinical entities. Both breakpoints were mediated by aberrant class switch recombination of the IGH locus. However, the 5' breakpoints (upstream) juxtaposed BCL3 next to an IGH enhancer leading to overexpression of the gene whereas the 3' breakpoints (downstream) positioned BCL3 outside the influence of the IGH and were not associated with its expression. Upstream BCL3-R tumors had unmutated IGHV, trisomy 12, and mutated genes frequently seen in chronic lymphocytic leukemia (CLL) but had an atypical CLL morphology, immunophenotype, DNA methylome, and expression profile that differ from conventional CLL. In contrast, downstream BCL3-R neoplasms were atypical splenic or nodal marginal zone lymphomas (MZL) with mutated IGHV, complex karyotypes and mutated genes typical of MZL. Two of the latter four tumors transformed to a large B-cell lymphoma. We designed a novel fluorescence in situ hybridization assay that recognizes the two different breakpoints and validated these findings in 17 independent tumors. Overall, upstream or downstream breakpoints of BCL3-R are mainly associated with two subtypes of lymphoid neoplasms with different (epi)genomic, expression, and clinicopathological features resembling atypical CLL and MZL, respectively.
RUO. Repositorio Institucional de la Universidad de Oviedo
Publicación Artículo científico (JournalArticle)

ATM germline variants in a young adult with chronic lymphocytic leukemia: 8 years of genomic evolution

  • Royo, R.
  • Magnano, L.
  • Delgado, J.
  • Ruiz Gil, S.
  • Gelpí, J. L.
  • Heyn, H.
  • Taylor, M. A.
  • Stankovic, T.
  • Suárez Puente, Xosé Antón|||0000-0001-9525-1483
  • Nadeu, F.
  • Campo, E.
The European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (810287, BCLLatlas, to EC, and HH), CERCA Program/Generalitat de Catalunya, Generalitat de Catalunya Suport Grups de Recerca AGAUR 2017-SGR-1142 (to EC), CIBERONC (CB16/12/00225 to EC), Ministerio de Ciencia e Innovación PID2020-117185RB-I00 (to XSP), FEDER...
RUO. Repositorio Institucional de la Universidad de Oviedo
Publicación Artículo científico (JournalArticle)

Detection of early seeding of Richter transformation in chronic lymphocytic leukemia

  • Nadeu, F.
  • Royo, R.
  • Massoni Badosa, R.
  • Suárez Puente, Xosé Antón|||0000-0001-9525-1483
(...) The European Research Council under the European Union’s Horizon 2020 Research and Innovation Program (810287, BCLLatlas, to E.C., J.I.M.-S., H.H. and I.G.), the Instituto de Salud Carlos III and the European Regional Development Fund Una Manera de Hacer Europa (PMP15/00007 to E.C. and RTI2018-094584-B-I00 to D.C.), the Centro de Investigación Biomédica en Red Cáncer (CIBERONC; CB16/12/00225, CB16/12/00334, CB16/12/00236), the Ministerio de Ciencia e Innovación (PID2020-117185RB-I00 to X.S.P.), H.P.-A. is a recipient of a predoctoral fellowship from the Spanish Ministry of Science, Innovation and Universities (FPU19/03110) (...), Nadeu, F., Royo, R., Massoni-Badosa, R., Playa-Albinyana, H., Garcia-Torre, B., Duran-Ferrer, M., Dawson, K.J., Kulis, M., Diaz-Navarro, A., Villamor, N., Melero, J.L., Chapaprieta, V., Dueso-Barroso, A., Delgado, J., Moia, R., Ruiz-Gil, S., Marchese, D., Giró, A., Verdaguer-Dot, N., Romo, M., Clot, G., Rozman, M., Frigola, G., Rivas-Delgado, A., Baumann, T., Alcoceba, M., González, M., Climent, F., Abrisqueta, P., Castellví, J., Bosch, F., Aymerich, M., Enjuanes, A., Ruiz-Gaspà, S., López-Guillermo, A., Jares, P., Beà, S., Capella-Gutierrez, S., Gelpí, J.L., López-Bigas, N., Torrents, D., Campbell, P.J., Gut, I., Rossi, D., Gaidano, G., Puente, X.S., Garcia-Roves, P.M., Colomer, D., Heyn, H., Maura, F., Martín-Subero, J.I., Campo, E.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

A method for multiplexed full-length single-molecule sequencing of the human mitochondrial genome

  • Keraite, Ieva
  • Becker, Philipp
  • Canevazzi, Davide
  • Frías-López, Cristina
  • Dabad, Marc
  • Leno Colorado, Jorge
  • Abulí Vidal, Anna
  • García Arumí, Elena
  • Tonda, Raul
Data processing; DNA sequencing; Genomic analysis, Tratamiento de datos; Secuenciación de ADN; Análisis genómico, Tractament de dades; Seqüenciació d'ADN; Anàlisi genòmica, Methods to reconstruct the mitochondrial DNA (mtDNA) sequence using short-read sequencing come with an inherent bias due to amplification and mapping. They can fail to determine the phase of variants, to capture multiple deletions and to cover the mitochondrial genome evenly. Here we describe a method to target, multiplex and sequence at high coverage full-length human mitochondrial genomes as native single-molecules, utilizing the RNA-guided DNA endonuclease Cas9. Combining Cas9 induced breaks, that define the mtDNA beginning and end of the sequencing reads, as barcodes, we achieve high demultiplexing specificity and delineation of the full-length of the mtDNA, regardless of the structural variant pattern. The long-read sequencing data is analysed with a pipeline where our custom-developed software, baldur, efficiently detects single nucleotide heteroplasmy to below 1%, physically determines phase and can accurately disentangle complex deletions. Our workflow is a tool for studying mtDNA variation and will accelerate mitochondrial research., This research has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 824110 – EASI-Genomics (I.G.G.) and the ERC Synergy project BCLL@las under grant agreement No 810287 (I.G.G.). Institutional support was from the Spanish Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias and cofunded with ERDF funds (PI19/01772). We acknowledge the institutional support of the Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III and the 2014–2020 Smart Growth Operating Program, to the EMBL partnership and institutional co-financing with the European Regional Development Fund (MINECO/FEDER, BIO2015-71792-P). We also acknowledge the support of the Centro de Excelencia Severo Ochoa, and the Generalitat de Catalunya through the Departament de Salut, Departament d’Empresa i Coneixement and the CERCA Programme to the institute.